A - AGILENT TECHNOLOGIES, INC.
106.28
-0.740 -0.696%
Share volume: 1,120,576
Last Updated: 04-25-2025
Measuring And Control Equipment/Lab Analytical Instruments:
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$107.02
-0.74
-0.01%
Fundamental analysis
57%
Profitability
31%
Dept financing
12%
Liquidity
73%
Performance
90%
Performance
5 Days
3.38%
1 Month
-10.67%
3 Months
-29.60%
6 Months
-19.20%
1 Year
-23.86%
2 Year
-20.24%
Key data
Stock price
$106.28
DAY RANGE
$104.35 - $106.43
52 WEEK RANGE
$96.43 - $155.35
52 WEEK CHANGE
-$23.86
DIVIDEND
$0.248
EX-DIVIDEND DATE
04-01-2025
NEXT EARNINGS DATE
05-28-2025
Company detail
CEO: Michael R. McMullen
Region: US
Website: agilent.com
Employees: 18,100
IPO year: 1999
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Region: US
Website: agilent.com
Employees: 18,100
IPO year: 1999
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, and genetic data management.
Recent news
